Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study

Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study

Fabrizio Martora,1 Claudio Marasca,2 Sara Cacciapuoti,1 Federica Fariello,1 Luca Potestio,1 Teresa Battista,1 Massimiliano Scalvenzi,1 Matteo Megna1 1Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy; 2Dermatology Unit, Medical Depa...

ver descrição completa

Detalhes bibliográficos
Principais autores: Martora F, Marasca C, Cacciapuoti S, Fariello F, Potestio L, Battista T, Scalvenzi M, Megna M
Formato: Artigo
Idioma:English
Publicado em: Dove Medical Press 2024-01-01
coleção:Clinical, Cosmetic and Investigational Dermatology
Assuntos:
hidradenitis suppurativa
secukinumab
adalimumab
treatments
Acesso em linha:https://www.dovepress.com/secukinumab-in-hidradenitis-suppurativa-patients-who-failed-adalimumab-peer-reviewed-fulltext-article-CCID

Internet

https://www.dovepress.com/secukinumab-in-hidradenitis-suppurativa-patients-who-failed-adalimumab-peer-reviewed-fulltext-article-CCID

Registros relacionados